Medindia LOGIN REGISTER
Medindia
Advertisement

FDA Not In Favor Of Legalizing Medical Marijuana

by Medindia Content Team on April 27, 2006 at 8:04 PM
FDA Not In Favor Of Legalizing Medical Marijuana

Advertisement
U.S. Food and Drug Administration (FDA) has categorically ruled out endorsing the use of marijuana for medical purposes. This decision contradicts an Institute of Medicine report in 1999, which had said that marijuana, also called as pot, was useful in certain conditions like AIDS wasting, chemotherapy induced nausea and vomiting and cancer cachexia.

In a statement issued on Thursday, the FDA stated that "no sound scientific studies supported medical use of marijuana for treatment in the United States, and no animal or human data supported the safety or efficacy of marijuana for general medical
Advertisement
use." This stand taken by the agency also pus question marks over states like Alaska, California, Colorado, Hawaii, Maine, Montana, Nevada, Oregon, Vermont and Washington that have legalized the use of marijuana as a medicine. The FDA is not in favor of legalizing the use of marijuana even if it is for medical purposes. "These measures are inconsistent with efforts to ensure that medications undergo the rigorous scientific scrutiny of the FDA approval process and are proven safe and effective.," it said. The FDA's decision means that the U.S. Drug Enforcement Agency (DEA) can take action against marijuana users even in states that have legalized it. Last year, a Supreme Court decision also found favor with authorities who arrested two California residents who were using the drug to relieve pain. One had brain cancer and the other severe back pain.
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Drug News

Can a Needle-Free Patch Transform Zika Protection?
Researchers create needle-free Zika vaccine patch, using HD-MAP tech, aiming to protect against fatal virus spread by mosquitoes.
Prolonging Market Exclusivity of Brand-name Insulin
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
FDA Boosts Orphan Drug Designations for Myelofibrosis Treatments
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
Anti-Rheumatic Drugs May Help Prevent Thyroid Disease
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.
Apotransferrin's Potential in Early Stroke Therapy Revealed
Human apotransferrin injected to mice models suffering from intracerebral hemorrhage was found to mitigate the serious effects of stroke.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

FDA Not In Favor Of Legalizing Medical Marijuana Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests